This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Regents of the University of Minnesota. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Liqiang Chen: Innovator in Therapeutic Compounds
Introduction
Liqiang Chen is a prominent inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer and therapeutic compounds. With a total of 2 patents, his work is paving the way for new treatments in the medical field.
Latest Patents
Liqiang Chen's latest patents include innovative compounds aimed at combating cancer. The first patent focuses on anticancer compounds, providing a general formula for compounds and their salts, which are designed for therapeutic use. The second patent involves therapeutic compounds that act as SIRT2 inhibitors, which are useful for treating conditions associated with SIRT2. These inventions highlight his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Liqiang Chen is affiliated with the Regents of the University of Minnesota, where he conducts his research and development. His work has garnered attention for its potential impact on cancer treatment and other health-related issues. His dedication to innovation in therapeutic compounds showcases his expertise and passion for improving healthcare.
Collaborations
Liqiang Chen collaborates with talented individuals such as Teng Ai and Swati Sudhakar. These partnerships enhance the research and development process, leading to more effective solutions in the field of medicinal chemistry.
Conclusion
Liqiang Chen is a notable inventor whose work in therapeutic compounds is making a significant impact in the medical field. His innovative patents and collaborations reflect his dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
